Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-063 PDE10A Occupancy Study in Healthy Volunteers
NCT02370602Phase 1Completed
- Sponsor
- Takeda
- Start
- Oct 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of balipodect (2 cohorts), sponsored by Takeda. Primary endpoint: Phosphodiesterase 10A (PDE10A) Occupancy of Brain Regions With [^11C]T-773 at 3 hours. Started Oct 2013; status: completed.
02
Drugs
balipodect
Beyond the preview
Go deeper on NCT02370602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02370602.